{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T09:15:42Z","timestamp":1778577342943,"version":"3.51.4"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"am","delay-in-days":276,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001082","name":"Camille and Henry Dreyfus Foundation Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001082","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000879","name":"Alfred P Sloan Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000879","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIH National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32GM008555"],"award-info":[{"award-number":["T32GM008555"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA016086"],"award-info":[{"award-number":["P30CA016086"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 Al173295"],"award-info":[{"award-number":["R01 Al173295"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006808","name":"University of North Carolina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bmc.2025.118371","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T15:21:04Z","timestamp":1756221664000},"page":"118371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Investigation of a cryptic ligand binding site on Plasmodium falciparum Hsp90"],"prefix":"10.1016","volume":"130","author":[{"given":"Christopher R.","family":"Mansfield","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth L.","family":"Taggart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Chirgwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily R.","family":"Derbyshire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2025.118371_bb0005","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41580-023-00640-9","article-title":"Structural and functional complexity of HSP90 in cellular homeostasis and disease","volume":"24","author":"Chiosis","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bmc.2025.118371_bb0010","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a034017","article-title":"Structure, function, and regulation of the Hsp90 machinery","volume":"11","author":"Biebl","year":"2019","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.bmc.2025.118371_bb0015","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrm.2017.20","article-title":"The HSP90 chaperone machinery","volume":"18","author":"Schopf","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bmc.2025.118371_bb0020","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3892\/or.2022.8443","article-title":"HSP90 inhibitors and cancer: prospects for use in targeted therapies (review)","volume":"49","author":"Li","year":"2022","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bmc.2025.118371_bb0025","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2174\/138161213804143608","article-title":"Heat shock protein 90 inhibitors as broad spectrum anti-infectives","volume":"19","author":"Rochani","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bmc.2025.118371_bb0030","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1073\/pnas.0813394106","article-title":"Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease","volume":"106","author":"Cowen","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bmc.2025.118371_bb0035","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.cstres.2024.03.007","article-title":"Plasmodium falciparum heat shock proteins as antimalarial drug targets: An update","volume":"29","author":"Ahmad","year":"2024","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.bmc.2025.118371_bb0040","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.cstres.2024.05.005","article-title":"An update on the status of HSP90 inhibitors in cancer clinical trials","volume":"29","author":"Rastogi","year":"2024","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.bmc.2025.118371_bb0045","doi-asserted-by":"crossref","first-page":"37964","DOI":"10.1074\/jbc.M110.155317","article-title":"Heat shock protein 90 as a drug target against protozoan infections","volume":"285","author":"Pallavi","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bmc.2025.118371_bb0050","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01799-17","article-title":"Identification of Hsp90 inhibitors with anti-plasmodium activity","volume":"62","author":"Posfai","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bmc.2025.118371_bb0055","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1021\/acsinfecdis.1c00322","article-title":"Prioritization of molecular targets for antimalarial drug discovery","volume":"7","author":"Forte","year":"2021","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bmc.2025.118371_bb0060","series-title":"World Malaria Report","author":"WHO","year":"2024"},{"key":"10.1016\/j.bmc.2025.118371_bb0065","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41573-023-00772-9","article-title":"Antimalarial drug discovery: progress and approaches","volume":"22","author":"Siqueira-Neto","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bmc.2025.118371_bb0070","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1073\/pnas.1114414109","article-title":"Charged linker sequence modulates eukaryotic heat shock protein 90 (Hsp90) chaperone activity","volume":"109","author":"Tsutsumi","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bmc.2025.118371_bb0075","doi-asserted-by":"crossref","first-page":"18336","DOI":"10.1074\/jbc.M211309200","article-title":"Heat shock protein 90 function is essential for plasmodium falciparum growth in human erythrocytes","volume":"278","author":"Banumathy","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bmc.2025.118371_bb0080","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1475-2875-2-30","article-title":"The heat shock protein 90 of plasmodium falciparum and antimalarial activity of its inhibitor, geldanamycin","volume":"2","author":"Kumar","year":"2003","journal-title":"Malar. J."},{"key":"10.1016\/j.bmc.2025.118371_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.chembiol.2024.02.008","article-title":"Selective targeting of plasmodium falciparum Hsp90 disrupts the 26S proteasome","author":"Mansfield","year":"2024","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.bmc.2025.118371_bb0090","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1128\/AAC.00328-12","article-title":"Harmine is a potent antimalarial targeting Hsp90 and synergizes with chloroquine and artemisinin","volume":"56","author":"Shahinas","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bmc.2025.118371_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075446","article-title":"A purine analog synergizes with chloroquine (CQ) by targeting plasmodium falciparum Hsp90 (PfHsp90)","volume":"8","author":"Shahinas","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2025.118371_bb0100","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1021\/jm901796s","article-title":"A repurposing strategy identifies novel synergistic inhibitors of plasmodium falciparum heat shock protein 90","volume":"53","author":"Shahinas","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bmc.2025.118371_bb0105","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1186\/s12936-016-1625-7","article-title":"In vitro and in vivo anti-malarial activity of novel harmine-analog heat shock protein 90 inhibitors: a possible partner for artemisinin","volume":"15","author":"Bayih","year":"2016","journal-title":"Malar. J."},{"key":"10.1016\/j.bmc.2025.118371_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127502","article-title":"Antimalarial activity of tetrahydro-\u03b2-carbolines targeting the ATP binding pocket of the plasmodium falciparum heat shock 90 protein","volume":"30","author":"Eagon","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bmc.2025.118371_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129410","article-title":"Synthesis and activity of \u03b2-carboline antimalarials targeting the plasmodium falciparum heat shock 90 protein","volume":"92","author":"Viswanathan","year":"2023","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bmc.2025.118371_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108468","article-title":"Solution structure of plasmodium falciparum Hsp90 indicates a high flexible dimer","volume":"690","author":"Silva","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bmc.2025.118371_bb0125","doi-asserted-by":"crossref","first-page":"12208","DOI":"10.1074\/jbc.M111874200","article-title":"Binding of ATP to heat shock protein 90: evidence for an ATP-binding site in the C-terminal domain","volume":"277","author":"Garnier","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bmc.2025.118371_bb0130","doi-asserted-by":"crossref","first-page":"37181","DOI":"10.1074\/jbc.M003701200","article-title":"The heat shock protein 90 antagonist Novobiocin interacts with a previously unrecognized ATP-binding domain in the carboxyl terminus of the chaperone","volume":"275","author":"Marcu","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bmc.2025.118371_bb0135","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1046\/j.1432-1033.2003.03610.x","article-title":"Comparative analysis of the ATP-binding sites of Hsp90 by nucleotide affinity cleavage: a distinct nucleotide specificity of the C-terminal ATP-binding site","volume":"270","author":"Soti","year":"2003","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bmc.2025.118371_bb0140","doi-asserted-by":"crossref","first-page":"7066","DOI":"10.1074\/jbc.M105568200","article-title":"A nucleotide-dependent molecular switch controls ATP binding at the C-terminal domain of Hsp90","volume":"277","author":"S\u00f6ti","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bmc.2025.118371_bb0145","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.mehy.2014.04.013","article-title":"Identifying a C-terminal ATP binding sites-based novel Hsp90-inhibitor in silico: a plausible therapeutic approach in Alzheimer's disease","volume":"83","author":"Khalid","year":"2014","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.bmc.2025.118371_bb0150","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/jnci\/92.3.242","article-title":"Novobiocin and related coumarins and depletion of heat shock protein 90-dependent signaling proteins","volume":"92","author":"Marcu","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bmc.2025.118371_bb0155","doi-asserted-by":"crossref","first-page":"8217","DOI":"10.1021\/bi0497998","article-title":"Novobiocin induces a distinct conformation of Hsp90 and alters Hsp90\u2212Cochaperone\u2212client interactions","volume":"43","author":"Yun","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2025.118371_bb0160","doi-asserted-by":"crossref","first-page":"6921","DOI":"10.1002\/chem.201504955","article-title":"Synthesis and biological evaluation of novobiocin core analogs as Hsp90 inhibitors","volume":"22","author":"Byrd","year":"2016","journal-title":"Chemistry"},{"key":"10.1016\/j.bmc.2025.118371_bb0165","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1124\/mol.109.058545","article-title":"KU135, a novel Novobiocin-derived C-terminal inhibitor of the 90-kDa heat shock protein, exerts potent Antiproliferative effects in human leukemic cells","volume":"76","author":"Shelton","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bmc.2025.118371_bb0170","doi-asserted-by":"crossref","first-page":"12778","DOI":"10.1021\/ja0535864","article-title":"Hsp90 inhibitors identified from a library of Novobiocin analogues","volume":"127","author":"Yu","year":"2005","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bmc.2025.118371_bb0175","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1039\/D3MD00529A","article-title":"Development of Hsp90 C-terminal inhibitors with noviomimetics that manifest anti-proliferative activities","volume":"15","author":"Amatya","year":"2024","journal-title":"RSC Med Chem"},{"key":"10.1016\/j.bmc.2025.118371_bb0180","doi-asserted-by":"crossref","first-page":"6450","DOI":"10.1074\/jbc.RA118.002502","article-title":"Stimulation of heat shock protein 90 chaperone function through binding of a novobiocin analog KU-32","volume":"294","author":"Chatterjee","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bmc.2025.118371_bb0185","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1021\/bi047433p","article-title":"Epigallocatechin Gallate inhibits aryl hydrocarbon receptor gene transcription through an indirect mechanism involving binding to a 90 kDa heat shock protein","volume":"44","author":"Palermo","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2025.118371_bb0190","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1021\/bi801637q","article-title":"(\u2212)-EPIGALLOCATECHIN-3-GALLATE is a novel HSP90 inhibitor","volume":"48","author":"Yin","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2025.118371_bb0195","doi-asserted-by":"crossref","first-page":"7859","DOI":"10.1021\/jo401027r","article-title":"Synthesis and structure activity relationships of EGCG analogues, a recently identified Hsp90 inhibitor","volume":"78","author":"Khandelwal","year":"2013","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bmc.2025.118371_bb0200","doi-asserted-by":"crossref","first-page":"10863","DOI":"10.1021\/jm301488q","article-title":"Design, synthesis, and biological evaluation of novel Deguelin-based heat shock protein 90 (HSP90) inhibitors targeting proliferation and angiogenesis","volume":"55","author":"Chang","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bmc.2025.118371_bb0205","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1158\/0008-5472.CAN-15-1492","article-title":"Deguelin analogue SH-1242 inhibits Hsp90 activity and exerts potent anticancer efficacy with limited neurotoxicity","volume":"76","author":"Lee","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.bmc.2025.118371_bb0210","doi-asserted-by":"crossref","first-page":"13924","DOI":"10.1038\/s41598-018-32196-6","article-title":"Development of a novel Hsp90 inhibitor NCT-50 as a potential anticancer agent for the treatment of non-small cell lung cancer","volume":"8","author":"Hyun","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bmc.2025.118371_bb0215","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1038\/s41388-022-02269-y","article-title":"A novel HSP90 inhibitor SL-145 suppresses metastatic triple-negative breast cancer without triggering the heat shock response","volume":"41","author":"Kim","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.bmc.2025.118371_bb0220","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0092-8674(00)80203-2","article-title":"Crystal structure of an Hsp90\u2013Geldanamycin complex: targeting of a protein chaperone by an antitumor agent","volume":"89","author":"Stebbins","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bmc.2025.118371_bb0225","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1002\/prot.22799","article-title":"Structure of the ATP-binding domain of plasmodium falciparum Hsp90","volume":"78","author":"Corbett","year":"2010","journal-title":"Proteins"},{"key":"10.1016\/j.bmc.2025.118371_bb0230","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1021\/acs.biochem.5c00015","article-title":"Structural insights into selectively targeting Candida albicans Hsp90","volume":"64","author":"Kowalewski","year":"2025","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2025.118371_bb0235","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/bioinformatics\/btr657","article-title":"Prediction and analysis of nucleotide-binding residues using sequence and sequence-derived structural descriptors","volume":"28","author":"Chen","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bmc.2025.118371_bb0240","first-page":"2849","article-title":"Inhibitors of the plasmodium falciparum Hsp90 towards selective antimalarial drug design: the past","volume":"10","author":"Stofberg","year":"2021","journal-title":"Present and Future Cells"},{"key":"10.1016\/j.bmc.2025.118371_bb0245","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.102666","article-title":"The known unknowns of the Hsp90 chaperone","volume":"13","author":"Silbermann","year":"2024","journal-title":"eLife"},{"key":"10.1016\/j.bmc.2025.118371_bb0250","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jmb.2016.01.029","article-title":"CryptoSite: expanding the Druggable proteome by characterization and prediction of cryptic binding sites","volume":"428","author":"Cimermancic","year":"2016","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bmc.2025.118371_bb0255","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2025.118371_bb0260","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2025.118371_bb0265","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bmc.2025.118371_bb0270","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1021\/bi062142x","article-title":"Functional interrogation of the Kinome using nucleotide acyl phosphates","volume":"46","author":"Patricelli","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2025.118371_bb0275","doi-asserted-by":"crossref","first-page":"13095","DOI":"10.1039\/C9RA09599C","article-title":"Bead based facile assay for sensitive quantification of native state green fluorescent protein","volume":"10","author":"Kim","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.bmc.2025.118371_bb0280","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1002\/cphc.201200117","article-title":"On-Bead Screens Sample Narrower Affinity Ranges of Protein\u2013Ligand Interactions Compared to Equivalent Solution Assays","volume":"13","author":"Hintersteiner","year":"2012","journal-title":"ChemPhysChem"},{"key":"10.1016\/j.bmc.2025.118371_bb0285","doi-asserted-by":"crossref","first-page":"19044","DOI":"10.1016\/S0021-9258(17)46733-0","article-title":"Structure of the alpha subunit of F1-ATPase probed by limited proteolysis","volume":"268","author":"Tozawa","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bmc.2025.118371_bb0290","doi-asserted-by":"crossref","first-page":"281","DOI":"10.18388\/abp.2008_3075","article-title":"Limited proteolysis of E. Coli ATP-dependent protease Lon - a unified view of the subunit architecture and characterization of isolated enzyme fragments","volume":"55","author":"Melnikov","year":"2008","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.bmc.2025.118371_bb0295","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1074\/jbc.M106120200","article-title":"Differential ATP binding and intrinsic ATP hydrolysis by amino-terminal domains of the yeast Mlh1 and Pms1 proteins","volume":"277","author":"Hall","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bmc.2025.118371_bb0300","first-page":"28.9.1","article-title":"Current protocols in protein science","volume":"79","author":"Huynh","year":"2015","journal-title":"Curr. Protoc. Protein Sci."},{"key":"10.1016\/j.bmc.2025.118371_bb0305","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00249-021-01513-9","article-title":"Standard protocol for mass photometry experiments","volume":"50","author":"Wu","year":"2021","journal-title":"Eur. Biophys. J."},{"key":"10.1016\/j.bmc.2025.118371_bb0310","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1038\/s41467-020-15642-w","article-title":"Quantifying the heterogeneity of macromolecular machines by mass photometry","volume":"11","author":"Sonn-Segev","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bmc.2025.118371_bb0315","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1074\/jbc.274.7.4133","article-title":"Heat-induced oligomerization of the molecular chaperone Hsp90. Inhibition by ATP and geldanamycin and activation by transition metal oxyanions","volume":"274","author":"Chadli","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bmc.2025.118371_bb0320","doi-asserted-by":"crossref","first-page":"15100","DOI":"10.1074\/jbc.M109.094698","article-title":"Biochemical and biophysical characterization of the Mg2+\u2212induced 90-kDa heat shock protein oligomers","volume":"285","author":"Moullintraffort","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bmc.2025.118371_bb0325","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1107\/S2059798322002261","article-title":"Crystal structure of the middle and C-terminal domains of Hsp90\u03b1 labeled with a coumarin derivative reveals a potential allosteric binding site as a drug target","volume":"78","author":"Peng","year":"2022","journal-title":"Acta Crystallogr D Struct Biol"},{"key":"10.1016\/j.bmc.2025.118371_bb0330","article-title":"The Hexameric structures of human heat shock protein 90","volume":"6","author":"Lee","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2025.118371_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2020.166788","article-title":"A fifth of the protein world: Rossmann-like proteins as an evolutionarily successful structural unit","volume":"433","author":"Medvedev","year":"2021","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bmc.2025.118371_bb0340","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1126\/science.aaf6846","article-title":"ATP as a biological hydrotrope","volume":"356","author":"Patel","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.bmc.2025.118371_bb0345","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/s41467-019-09107-y","article-title":"Proteome-wide solubility and thermal stability profiling reveals distinct regulatory roles for ATP","volume":"10","author":"Sridharan","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bmc.2025.118371_bb0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003831","article-title":"The structural basis of ATP as an allosteric modulator","volume":"10","author":"Lu","year":"2014","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.bmc.2025.118371_bb0355","doi-asserted-by":"crossref","first-page":"D510","DOI":"10.1093\/nar\/gkt1247","article-title":"ASD v2.0: updated content and novel features focusing on allosteric regulation","volume":"42","author":"Huang","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bmc.2025.118371_bb0360","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.cell.2017.12.006","article-title":"A map of protein-metabolite interactions reveals principles of chemical communication","volume":"172","author":"Piazza","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.bmc.2025.118371_bb0365","series-title":"Chemogenomics: Methods and Protocols","first-page":"177","article-title":"Target deconvolution by limited proteolysis coupled to mass spectrometry","author":"Reber","year":"2023"},{"key":"10.1016\/j.bmc.2025.118371_bb0370","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0167-4838(97)00175-1","article-title":"The structural aspects of limited proteolysis of native proteins","volume":"1382","author":"Hubbard","year":"1998","journal-title":"Biochim. Biophys. Acta Protein Struct. Mol. Enzymol."},{"key":"10.1016\/j.bmc.2025.118371_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.129111","article-title":"Recent advances toward the development of Hsp90 C-terminal inhibitors","volume":"80","author":"Amatya","year":"2023","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bmc.2025.118371_bb0380","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1021\/cb200052x","article-title":"Elucidation of the Hsp90 C-terminal inhibitor binding site","volume":"6","author":"Matts","year":"2011","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bmc.2025.118371_bb0385","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1021\/ct100334n","article-title":"Dynamics-based discovery of allosteric inhibitors: selection of new ligands for the C-terminal domain of Hsp90","volume":"6","author":"Morra","year":"2010","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.bmc.2025.118371_bb0390","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1021\/ci4005767","article-title":"Exploiting conformational dynamics in drug discovery: design of C-terminal inhibitors of Hsp90 with improved activities","volume":"54","author":"Moroni","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bmc.2025.118371_bb0395","doi-asserted-by":"crossref","first-page":"13598","DOI":"10.1002\/chem.201502211","article-title":"Activation of Hsp90 enzymatic activity and conformational dynamics through rationally designed allosteric ligands","volume":"21","author":"Sattin","year":"2015","journal-title":"Chemistry"},{"key":"10.1016\/j.bmc.2025.118371_bb0400","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jmgm.2016.10.002","article-title":"In silico identification and computational analysis of the nucleotide binding site in the C-terminal domain of Hsp90","volume":"70","author":"Roy","year":"2016","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.bmc.2025.118371_bb0405","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/s41598-018-35835-0","article-title":"Modulation of human Hsp90\u03b1 conformational dynamics by allosteric ligand interaction at the C-terminal domain","volume":"9","author":"Penkler","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bmc.2025.118371_bb0410","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1021\/ci1001857","article-title":"Exploring the binding site of C-terminal Hsp90 inhibitors","volume":"50","author":"Sgobba","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bmc.2025.118371_bb0415","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1074\/jbc.M512406200","article-title":"Modulation of chaperone function and Cochaperone interaction by Novobiocin in the C-terminal domain of Hsp90: Evidence that coumarin antibiotics disrupt Hsp90 dimerization","volume":"281","author":"Allan","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bmc.2025.118371_bb0420","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.chembiol.2016.05.012","article-title":"In vivo conformational dynamics of Hsp90 and its interactors","volume":"23","author":"Chavez","year":"2016","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.bmc.2025.118371_bb0425","doi-asserted-by":"crossref","first-page":"23830","DOI":"10.1038\/srep23830","article-title":"Molecular dynamics simulations reveal the mechanisms of allosteric activation of Hsp90 by designed ligands","volume":"6","author":"Vettoretti","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bmc.2025.118371_bb0430","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12551-020-00619-2","article-title":"Theory and applications of differential scanning fluorimetry in early-stage drug discovery","volume":"12","author":"Gao","year":"2020","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.bmc.2025.118371_bb0435","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/embor.2009.153","article-title":"Hsp90 is regulated by a switch point in the C-terminal domain","volume":"10","author":"Retzlaff","year":"2009","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bmc.2025.118371_bb0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00928361","article-title":"Physiological concentrations of purines and pyrimidines","volume":"140","author":"Traut","year":"1994","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bmc.2025.118371_bb0445","doi-asserted-by":"crossref","first-page":"W276","DOI":"10.1093\/nar\/gkac240","article-title":"Search and sequence analysis tools services from EMBL-EBI in 2022","volume":"50","author":"Madeira","year":"2022","journal-title":"Nucleic Acids Res."}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625003128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625003128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:33:21Z","timestamp":1778574801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089625003128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":89,"alternative-id":["S0968089625003128"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118371","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of a cryptic ligand binding site on Plasmodium falciparum Hsp90","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118371","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118371"}}